Fabrice JOVER
General Manager IBSA Pharma - IBSA Group at IBSA Pharma- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
IBSA France
-
France
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
General Manager IBSA Pharma - IBSA Group
-
Dec 2020 - Present
Provence-Alpes-Côte d’Azur, France Leading operations including in-house biotechnology research departement. Spezialized in Fertility, Rhumatology, Dermatology, Urology, Endocrinology and Dermo-aesthetic
-
-
-
-
Managing Director JVR consulting
-
Feb 2020 - Nov 2020
Pharma, Medtech and e-plateform consultant
-
-
-
Aspen Pharma Group
-
South Africa
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Global External Affairs and Alliances Head
-
Apr 2018 - Jun 2020
Région de Paris, France Global Executive position: leading Aspen Reputation, Creating & managing external affairs dedicated to access and pricing. Generating alliances through public-private partnerships across EU regions. Active member of the above countries CEO Commercial Head Strategic Group. Managing the acting Canadian GM (Toronto) - From Feb. to Oct.19 - 1 Week/ month in Canada - Material turn-around in sales and profit in a very short notice period leading to achieve results above budget (105%)
-
-
General Manager France & Benelux
-
Nov 2013 - Apr 2018
Région de Paris, France Sustainable Delivery and performant organisation in place. Growing Thrombosis and Acquiring various portfolios (Anesthetics from AZ and GSK in 2017). Creating and leading Commercial Operations at ASPEN in France and Benelux. Lead the organisation to ensure competitiveness in order to reach ambitions of the key south- hemisphere pharmaceutical company ASPEN. Domains: Thrombosis, Anesthesia, Oncology and Woman Health Appointing leadership team, managing the Benelux GM and create momentum… Show more Sustainable Delivery and performant organisation in place. Growing Thrombosis and Acquiring various portfolios (Anesthetics from AZ and GSK in 2017). Creating and leading Commercial Operations at ASPEN in France and Benelux. Lead the organisation to ensure competitiveness in order to reach ambitions of the key south- hemisphere pharmaceutical company ASPEN. Domains: Thrombosis, Anesthesia, Oncology and Woman Health Appointing leadership team, managing the Benelux GM and create momentum for anti-thrombosis, anesthetics, Oncology and Women's Health areas.
-
-
-
GSK
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Directeur Business Unit Soins Spécialisés
-
Nov 2012 - Oct 2013
Marly le Roi Been promoted from Sales and Marketing Director at Primary Care to Secondary Care Business Unit Director at GSK from the 1rst of November 2012. Direct reports: 3 Sales and Marketing Directors leading 170 Sales (Hospital/ specialists and GP reps) and Marketing people in Thrombosis - Urology and CNS areas.
-
-
Area Marketing & Sales Director Respiratory and Osteoporosis
-
Mar 2012 - Oct 2012
France Leading a Sales and Marketing organisation with a focus on product launching in Osteoporosis Driving P&L in concordance with GSK expectation Interfacing with counterparts as AMGEN and ASTELLAS and building up relationships with them
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Sales Director at AZ France
-
Aug 2009 - Aug 2012
Leading 120 reps and 10 Area Sales manager with the whole AZ Primary Care portfolio
-
-
Global Nexium Commercial Leader (living in Sweden)
-
Jan 2008 - Jul 2009
Promoted from Global Brand director to a more Executive Role: Global Commercial leader. Providing commercial (US and RoW) leadership of the GI AZ portfolio, defining and delivering strategy and life cycle management plans to maximize Nexium opportunityTeam Management 20. Direct reports 9: Market Access Director, Business Insight Director, Global Brand Managers and Brand Communication Directors
-
-
Global Brand Director Nexium & GI Established Brands (living in Sweden)
-
Jan 2005 - Dec 2007
Optimizing the profitability of AZ GI Established Brands and driving Nexium Life Cycle and Global/ Regional opportunities - reporting to the Nexium Commercial leader. Team management 15 - Direct reports 11: Global Brand Managers, Medical Affairs Managers, Publication Managers, key relations Managers and e-Business Managers
-
-
GI Marketing Director in France
-
Jan 2001 - Dec 2004
Launch of Nexium in France. Co-positionning with Losec. Team Management: 9 (3 direct reports: 2 Group Managers and 1 Business Planning Manager))
-
-
CV Group Manager.
-
Sep 1997 - Dec 2000
Leading 3 Product Managers. Launch of ATACAND (Anti-hypertensive Drug) - Co- Marketing with TAKEDA (KENZEN)
-
-
Product Manager
-
Aug 1993 - Aug 1997
Delivering stratégy for Plendil (Calcium Antagonist) - Seloken (Beta Blocker) and launch of Logimax (Fixed combination of Plendil and Logimax)
-
-
-
Bristol Myers Squibb
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Product Manager
-
Feb 1992 - Jul 1993
Delivering opérationnal strategy for Pravastatine (ELISOR in France) - a lipid lowering Agent
-
-
-
-
Product Manager
-
Apr 1990 - Jan 1992
Product Manager with a large portfolio of OTC and semi-ethical Brands
-
-
-
-
Sales representative
-
Oct 1988 - Mar 1990
Sales representative and Communication Manager for a Credit Card : Aurora - in Belgium
-
-
Education
-
Université Pharmacie Paris
PhD Pharmacist, Healthcare -
ISG Institut Supérieur de Gestion
Master Business School, Business -
Université de Droit - Paris - Sceaux
Master's degree, Law Heatlhcare